){kind=logo}
Loeb & Loeb LLP is proud to sponsor the American Conference Institute (ACI)'s 13th Annual Paragraph IV Disputes taking place on April 29-30, 2019, where partner Mark Waddell will be speaking on the panel “Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum".
About the event:
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
About the event:
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
-
Chair, Patent Litigation ＆ Counseling